AI 摘要
我们查看了 fasenra benralizumab 的 4 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Monoclonal Antibodies 和 Biologics。
Compare with TopFind
实时搜索
正在加载实时结果
TopFind 正在为你的搜索抓取最新匹配结果。
实时搜索
TopFind 正在为你的搜索抓取最新匹配结果。
我们查看了 fasenra benralizumab 的 4 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Monoclonal Antibodies 和 Biologics。
来源: AstraZeneca Malaysia
描述
Fasenra (Benralizumab) is an immunomodulatory biologic available in a 30mg pre-filled pen, typically used for severe eosinophilic asthma.
适用场景
Severe asthma, Eosinophilic conditions 和 Monoclonal antibody therapy
评分
来源: AstraZeneca Pharmaceuticals (Phils.), Inc.
描述
Fasenra is a prescription biologic medication used as an add-on maintenance treatment for adults and children aged 6 years and older with severe eosinophilic asthma. As a monoclonal antibody, it targets and removes eosinophils, a type of white blood cell that causes lung inflammation. It is administered via subcutaneous injection, typically every 4 weeks for the first three doses and every 8 weeks thereafter, using a single-dose pre-filled syringe or the Fasenra Pen autoinjector.
适用场景
Severe eosinophilic asthma patients, Biologic maintenance therapy, Long Term asthma control 和 Pediatric and adult patients
评分
来源: Medindia
描述
Availability of Fasenra (benralizumab) 30mg/1ml injections for delivery to various regions, including the Philippines. This channel provides a digital platform for ordering the biologic medication, provided that a valid medical prescription is submitted for verification and fulfillment.
适用场景
Online prescription fulfillment, International pharmaceutical shipping, Patients with valid prescriptions 和 Home delivery preference
评分
| 比较 | Fasenra | Fasenra (benralizumab) | Fasenra 30mg/1ml Injection |
|---|---|---|---|
| 来源 | AstraZeneca Malaysia | AstraZeneca Pharmaceuticals (Phils.), Inc. | Medindia |
| 描述 | Fasenra (Benralizumab) is an immunomodulatory biologic available in a 30mg pre-filled pen, typically used for severe eosinophilic asthma. | Fasenra is a prescription biologic medication used as an add-on maintenance treatment for adults and children aged 6 years and older with severe eosinophilic asthma. As a monoclonal antibody, it targets and removes eosinophils, a type of white blood cell that causes lung inflammation. It is administered via subcutaneous injection, typically every 4 weeks for the first three doses and every 8 weeks thereafter, using a single-dose pre-filled syringe or the Fasenra Pen autoinjector. | Availability of Fasenra (benralizumab) 30mg/1ml injections for delivery to various regions, including the Philippines. This channel provides a digital platform for ordering the biologic medication, provided that a valid medical prescription is submitted for verification and fulfillment. |
| 适用场景 | Severe asthma, Eosinophilic conditions 和 Monoclonal antibody therapy | Severe eosinophilic asthma patients, Biologic maintenance therapy, Long Term asthma control 和 Pediatric and adult patients | Online prescription fulfillment, International pharmaceutical shipping, Patients with valid prescriptions 和 Home delivery preference |
| 操作 | |||
| 评分 |
如果你想先看最均衡的选择，我推荐：
"Fasenra 来自 AstraZeneca Malaysia."
我选择它是因为 A modern biologic option for managing severe respiratory conditions through immune pathway targeting.